Psicosis

Discontinuation of antipsychotic medication—time to rethink trial design

23/09/2020 | Psicosis

The Lancet Psychiatry Fecha de publicación: October 2020 DOI: https://doi.org/10.1016/S2215-0366(20)30340-0 Autores: Helene Speyer, Marieke Begemann, Nikolai Albert, Amber Weller, Merete Nordentoft, Wim Veling...

Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study

20/07/2020 | Psicosis

Lancet Psychiatry Fecha de publicación: July 2020 DOI: https://doi.org/10.1016/S2215-0366(20)30147-4 Autores: Richard J Drake, PhD , Prof Nusrat Husain, MD, Prof Max Marshall, MD, Prof...

Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study

22/06/2020 | Psicosis

Lancet Psychiatry Fecha de publicación: July 2020 DOI: https://doi.org/10.1016/S2215-0366(20)30147-4 Autores: Richard J Drake, PhD.,Prof Nusrat Husain, MD., Prof Max Marshall,...

Maternal perinatal depressive symptoms and offspring psychotic experiences at 18 years of age: a longitudinal study

20/05/2020 | Psicosis

Lancet Psychiatry Fecha de publicación: May 2020 DOI: https://doi.org/10.1016/S2215-0366(20)30132-2 Autores: Ramya Srinivasan, BMBCh., Rebecca M Pearson, PhD., Prof Sonia Johnson,...

Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk

24/02/2020 | Psicosis

American Journal of Psychiatry Fecha de publicación: 12 November 2019 DOI: https://doi.org/10.1176/appi.ajp.2019.18060721 Autores: Diana O. Perkins, M.D., M.P.H., Loes Olde...